The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
25 07 2023
Historique:
received: 19 08 2022
revised: 28 02 2023
accepted: 14 06 2023
medline: 31 7 2023
pubmed: 6 7 2023
entrez: 6 7 2023
Statut: ppublish

Résumé

The redox regulator NRF2 becomes activated upon oxidative and electrophilic stress and orchestrates a response program associated with redox regulation, metabolism, tumor therapy resistance, and immune suppression. Here, we describe an unrecognized link between the integrated stress response (ISR) and NRF2 mediated by the ISR effector ATF4. The ISR is commonly activated after starvation or ER stress and plays a central role in tissue homeostasis and cancer plasticity. ATF4 increases NRF2 transcription and induces the glutathione-degrading enzyme CHAC1, which we now show to be critically important for maintaining NRF2 activation. In-depth analyses reveal that NRF2 supports ATF4-induced cells by increasing cystine uptake via the glutamate-cystine antiporter xCT. In addition, NRF2 upregulates genes mediating thioredoxin usage and regeneration, thus balancing the glutathione decrease. In conclusion, we demonstrate that the NRF2 response serves as second layer of the ISR, an observation highly relevant for the understanding of cellular resilience in health and disease.

Identifiants

pubmed: 37410595
pii: S2211-1247(23)00735-0
doi: 10.1016/j.celrep.2023.112724
pii:
doi:

Substances chimiques

Activating Transcription Factor 4 145891-90-3
ATF4 protein, human 0
Cystine 48TCX9A1VT
Glutathione GAN16C9B8O
NF-E2-Related Factor 2 0
NFE2L2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112724

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Julia Katharina Charlotte Kreß (JKC)

Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany.

Christina Jessen (C)

Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany.

Anita Hufnagel (A)

Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany.

Werner Schmitz (W)

Department of Biochemistry and Molecular Biology, University of Würzburg, 97074 Würzburg, Germany.

Thamara Nishida Xavier da Silva (TN)

Rudolf-Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, 97080 Würzburg, Germany.

Ancély Ferreira Dos Santos (A)

Rudolf-Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, 97080 Würzburg, Germany.

Laura Mosteo (L)

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK; Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4200-135 Porto, Portugal.

Colin R Goding (CR)

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.

José Pedro Friedmann Angeli (JP)

Rudolf-Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, 97080 Würzburg, Germany.

Svenja Meierjohann (S)

Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany. Electronic address: svenja.meierjohann@uni-wuerzburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH